Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Victor Ajayi | Drug Discovery and Development | Best Researcher Award

Mr Victor Ajayi, University of Medical sciences Ondo Nigeria, Nigeria

Mr. Oluwadamilola Victor Ajayi is a distinguished academic and researcher in human physiology 🧬, with a B.Tech, M.Sc., and M.Phil. from reputable institutions. His groundbreaking research focuses on anti-ulcerogenic and antioxidant effects, phytochemical profiling, and bioactive compounds’ therapeutic roles 🩺. With over a decade of teaching experience at UNIMED 🎓, he excels in curriculum development and research mentorship. A member of esteemed bodies like PSN and Physoc 🏅, Mr. Ajayi actively engages in advancing physiology through publications and conferences. His dedication to science and education makes him a standout contributor in his field 🌍.

Publication Profile

orcid

Educational Backgrounds

Victor Ajayi’s academic journey spans several prestigious institutions. He is currently pursuing an M.Phil in Human Physiology at the Federal University of Technology, Akure (FUTA), starting in November 2024. He previously attended the University of Medical Sciences (UNIMED), Ondo, from August 2022 to December 2024, and earned his M.Sc. in Human Physiology from the University of Ibadan in November 2018. Victor completed his B.Tech in Human Physiology at Ladoke Akintola University of Technology (LAUTECH) in November 2011. His earlier academic milestones include WAEC (2009) and NECO (2002). 🎓📚👨‍🎓

Work Experience

Victor Ajayi has a diverse work experience spanning various roles in academia and healthcare. He started with industrial training as a Technologist at Spring Specialist Hospital in 2010, followed by NYSC at Ondo State School of Nursing, where he taught Physiology and Anatomy. Victor later worked as a teacher and guest tutor at different institutions, including Integrity Nursery, Ondo State School of Nursing, and several colleges. At the University of Medical Sciences, he serves as an Assistant Lecturer, course coordinator, and level adviser, while also supervising graduate students. His contributions to Physiology education remain invaluable. 🏥📚👨‍🏫

Membership

Mr. Victor Ajayi D. is an active member of esteemed professional bodies such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc). Over the years, he has attended several notable conferences and workshops, including the 28th and 29th Scientific Conferences of PSN at the University of Ilorin in 2008 and 2009, and the 31st conference at Lagos State University in 2011. He also participated in workshops on pedagogy, effective communication, animal ethics, and integrated registration. His dedication to continued learning is evident in his certified seminar attendance, such as the Bioinformatics and Genomics course in October 2024. 📚🔬🧑‍🏫

Community and Professional Engagement

Mr. Victor Ajayi has consistently showcased remarkable leadership in professional communities. As a dedicated member of esteemed organizations such as the Physiological Society of Nigeria (PSN) and The Physiological Society (Physoc), he has made significant contributions to the advancement of his field. His active participation in numerous conferences and workshops underscores his commitment to continuous learning and staying at the forefront of his profession. Through these engagements, Mr. Ajayi has demonstrated a passion for professional growth and a commitment to fostering collaboration within the scientific community. His involvement continues to inspire and influence others in the field. 💼📚

Accolades and Recognition

Mr. Victor Ajayi has made significant contributions to research, education, and professional development, positioning him as a strong contender for the Best Researcher Award. Although his CV does not highlight specific prior awards, his innovative approaches to addressing physiological challenges and his commitment to advancing scientific knowledge demonstrate his potential. Additionally, his dedication to mentoring the next generation of researchers reflects his passion for nurturing talent and fostering academic growth. Mr. Ajayi’s work continues to inspire and impact the research community, showcasing his outstanding ability to drive change and innovation in his field. 🏆📚🔬

Research Focus

Mr. Victor Ajayi’s research focuses on the anti-inflammatory and anti-oxidative effects of pasteurized yoghurt in mitigating gastric ulceration induced by indomethacin in male Wistar rats. This study delves into gastrointestinal health and the potential therapeutic benefits of food-based interventions in inflammatory conditions. His work contributes to pharmacology, nutritional science, and biomedical research with an emphasis on how diet and natural substances can influence disease progression and provide alternative treatments. This aligns with the field of Pharmacological Toxicology and Gastroenterology, exploring the intersection of nutrition and pharmacology in disease management. 🧑‍⚕️🍽️💊

Publication Top Notes

Anti-inflammatory and anti-oxidative effect of pasterurised yoghurt in indomethacin induced gastric ulceration in male Wistar rats

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Published on by Top Pharmaceutical

Michael Swedberg | Drug Discovery and Development | Best Researcher Award

Dr Michael Swedberg, Swedberg Preclinical Partner, Sweden

Dr. Michael Swedberg is a distinguished pharmacologist with extensive expertise in safety pharmacology, CNS pharmacology, gastrointestinal pharmacology, and drug abuse assessment. He has held key leadership roles, including Associate Director at AstraZeneca and founder of Swedberg Preclinical Partner AB. His global impact includes contributions to regulatory compliance, developing novel animal models, and mentoring future researchers. With a Ph.D. in discrimination learning and postdoctoral training at NIDA, Dr. Swedberg has collaborated internationally and received numerous accolades for his innovative research and leadership. His career embodies excellence in pharmacology and preclinical drug discovery. 🌍💊🔬

Publication Profile

scopus

Education

Dr. Michael Swedberg is a distinguished academic and researcher, having earned his Ph.D. in 1985 from the University of Uppsala, Sweden. His doctoral dissertation focused on “A Model of Discrimination Learning with Interoceptive Stimuli.” He completed his postdoctoral fellowship at the National Institutes of Health (NIH), specializing in addiction research at the National Institute on Drug Abuse’s Preclinical Pharmacology Branch in Baltimore, Maryland (1985–1988). Additionally, Dr. Swedberg holds a Bachelor of Social Science (B.S.Sc.) from Uppsala University, with a comprehensive background in psychology, sociology, and law. 🧠📚🎓

Professional Appointments

Dr. Michael Swedberg has had an extensive and distinguished career in pharmacology and drug discovery. From 2014 to 2021, he was the Founder and CEO of Swedberg Preclinical Partner AB in Sweden. Prior to that, he was a Partner and Consultant at The Research Network (TRN) from 2014 to 2016. His earlier career includes key roles at AstraZeneca R&D, where he served as Associate Director in Safety Pharmacology and Preclinical Development. He also held senior leadership positions at Novo Nordisk and Ferrosan. Dr. Swedberg’s journey began as a Lecturer at Mälardalen University in 1981. 🧑‍🔬💉📚

Academic Service

Dr. Michael Swedberg has made significant contributions to the field of pharmacology and neuroscience through various roles. He served as a board member for the Department of Psychology at the University of Uppsala and the Faculty of Social Sciences from 1980 to 1985. His leadership extended to chairing the Council of Graduate Students. Recognized for his service, Dr. Swedberg received awards from the Drug Abuse Liability Ad Hoc Committee and for his work with the Lilly–Novo Nordisk Muscarinic Research Collaboration. He has also been a grant evaluator for the European Union and Poland’s National Centre for Research and Development. 🌍🔬🧠

Presentations

Dr. Michael Swedberg has made significant contributions to the field of drug safety and abuse liability assessment. His research, presented at multiple prestigious meetings, includes the role of drug discrimination studies in evaluating novel compounds’ abuse potential. Notably, his work at the Safety Pharmacology Society, American College of Toxicology, and the Swedish Pharmaceutical Congress has advanced methodologies like rat self-administration and drug discrimination for psychoactive effects. His work on the interaction between mGluR5 antagonists and benzodiazepines also stands out. Swedberg’s contributions to safety pharmacology have had a lasting impact on CNS drug development and regulatory guidelines. 🧠💊

Lecturing and teaching

Dr. Michael Swedberg has delivered extensive lectures and seminars on safety pharmacology, drug abuse, and CNS risk assessment. His contributions include lectures at the American College of Toxicology, Safety Pharmacology Society, and the European Congress of Toxicologic Pathology, focusing on drug dependence, abuse liability, and CNS safety. Additionally, Swedberg has provided in-depth training on the regulatory and industrial challenges in drug development at AstraZeneca and other global platforms. His teaching spans from the biomedical program at Karolinska Institute to the University of Uppsala, covering neuropharmacology, psychopharmacology, and drug addiction. His educational materials are widely respected in the field. 🧠📚💊

Academic Supervision

Dr. Michael Swedberg has mentored numerous students at various stages of their academic careers, including graduate, Ph.D., and postdoctoral researchers. He supervised students at Umeå University, University of Uppsala, and Karolinska Institute, guiding experimental work in fields such as cannabinoid tolerance, dopamine release, and nicotine’s effects on learning. His postdoctoral supervision included projects on visual and auditory discrimination in drug testing. Swedberg’s research has been supported by multiple prestigious grants, such as the Clas Groschinsky Memorial Foundation and the Swedish Medical Research Council. His contributions have significantly advanced brain and behavior research. 🎓🧠💡

Committee Service

Dr. Michael Swedberg held several key roles at AstraZeneca, including membership in the Safety Knowledge Group for CNS and leadership in CNS GLP Safety Pharmacology Harmonization. He was also a part of multiple committees, such as the AstraZeneca Expert Advisory Group on Abuse Liability and the Cross Company Abuse Liability Consortium. Dr. Swedberg contributed to international organizations like PhRMA and CPDD, focusing on drug abuse liability. He attended professional courses in safety pharmacology, project management, and leadership, further enhancing his expertise. Additionally, he completed a teaching course at Karolinska Institute, strengthening his academic influence. 🧠💊🎓

Research Focus

Dr. Michael Swedberg’s research focuses on the pharmacology of muscarinic receptors and their potential therapeutic applications, particularly in relation to neurological and psychiatric disorders. His work has delved into muscarinic receptor agonists, with significant contributions to the understanding of their antipsychotic and antinociceptive properties. Additionally, he has explored the role of nicotinic compounds and their reinforcing effects. His research has implications for treating conditions like schizophrenia, Alzheimer’s disease, and irritable bowel syndrome. 🧠🔬💊 His studies on receptor-ligand interactions and pharmacological profiles contribute to the development of novel drugs for various neurological and gastrointestinal conditions.

Publication Top Notes

Approaches for early identification of abuse potential liability

Drug discrimination: A versatile tool for characterization of CNS safety pharmacology and potential for drug abuse

Drug Discrimination: Use in Preclinical Assessment of Abuse Liability

AZD9272 and AZD2066: Selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects

Prediction and modeling of effects on the QTc interval for clinical safety margin assessment, based on single-ascending-dose study data with AZD3839

A multi-site comparison of in vivo safety pharmacology studies conducted to support ICH S7A & B regulatory submissions

Establishment of auditory discrimination and detection of tinnitus induced by salicylic acid and intense tone exposure in the rat

Dr. Rahim Dehghan|Pharmaceutical Biotechnology| Best Researcher Award

Published on by Top Pharmaceutical

Dr. Rahim Dehghan|Pharmaceutical Biotechnology |Best Researcher Award|

Dr. Rahim Dehghan at mus alparslan university, Turkeys

PROFILE  

scopus

Google Sholar

 

Early Academic Pursuits 🎓

Rahim Dehghan embarked on his academic journey in the field of polymer engineering at Shiraz University, where he earned his bachelor’s degree in 2011. Driven by a deep curiosity and passion for polymer science, he pursued a master’s degree in polymer engineering at Yazd University, completing it in 2015. His master’s thesis was a significant exploration of blood-compatible membranes, a topic that laid the foundation for his future research endeavors. This period of academic training provided him with a robust understanding of polymer materials and their applications in biomedical engineering, particularly in the development of membranes for medical use.

Professional Endeavors and Research Focus 🧪

Dehghan’s professional career has been marked by a series of research positions and projects that have focused on the development and enhancement of synthetic membranes for biomedical applications. In 2016, he commenced his Ph.D. at the prestigious Iran Polymer and Petrochemical Institute, a leading center for polymer education in Iran. His doctoral research was centered on developing membranes for the separation of low-density lipoprotein (LDL), commonly known as bad cholesterol, from blood plasma. This work was groundbreaking, as it addressed critical challenges in blood purification technologies, aiming to improve the efficiency and efficacy of these processes.

During his Ph.D. studies, Dehghan worked on several key aspects of membrane engineering, including pore size optimization, morphology control, and enhancing membrane permeability. His innovative approach to membrane structural engineering was aimed at achieving high-performance membranes capable of selective separation of LDL from blood plasma, while ensuring high plasma permeability. His research contributions during this period culminated in a Ph.D. degree, awarded in 2022 with an excellent grade, reflecting the significance and quality of his work.

Contributions and Research Focus 🌍

Dehghan’s research has had a profound impact on the field of membrane science, particularly in the development of membranes for biomedical applications. His work on LDL separation has opened new avenues for research in blood purification technologies, with potential applications in treating cardiovascular diseases and other conditions where blood purification is critical. He has also contributed to the field of microfiltration membranes for plasmapheresis, a process used to separate plasma from blood cells. His recent work has successfully developed a microfiltration membrane capable of simultaneously separating LDL and blood cells from whole blood, a significant advancement in this area.

In addition to his academic research, Dehghan has played a crucial role in the industrial application of his findings. As a researcher at the Iranian Polymer and Petrochemical Institute and a senior researcher at D.G.DENA Co., he has applied his expertise to the development of biomedical devices, including hydrogels and gels for wound care. His work in these roles has involved the application of advanced polymer science to address real-world challenges in medical device manufacturing.

Accolades and Recognition 🏆

Throughout his academic and professional career, Dehghan has received numerous accolades that highlight his contributions to the field of polymer engineering. One of his early achievements was acquiring the 8th rank in the national Ph.D. entrance exam in Iran in 2016, a highly competitive examination with over 400 participants. This accomplishment not only earned him a prestigious scientific award but also set the stage for his successful academic career.

His research has been widely recognized and published in several leading international journals, including the Journal of Membrane Science and Separation and Purification Technology. These publications have not only disseminated his findings to the broader scientific community but have also established him as a leading researcher in the field of polymer-based membrane technologies.

Impact and Influence 🌟

Dehghan’s work has had a significant impact on both the academic and industrial sectors. His research on membrane technologies has provided new insights into the design and development of high-performance membranes for medical applications. These contributions are particularly important in the context of blood purification technologies, where efficient and selective separation processes are critical for patient outcomes.

In the industrial sphere, his work as a consultant and researcher has directly influenced the development of new medical devices, particularly in the area of wound care. His expertise in polymer science has been instrumental in advancing the capabilities of these devices, ensuring they meet the stringent requirements of biomedical applications.

Legacy and Future Contributions 🌠

Looking ahead, Rahim Dehghan’s contributions to the field of polymer engineering and membrane science are poised to leave a lasting legacy. His work has already set new standards for the development of synthetic membranes, particularly in the biomedical field. As he continues to explore new research opportunities, particularly in the field of blood purification membranes such as hemodialysis and hemodiafiltration, his impact on the field is expected to grow.

🎓Publication 

Dextran sulfate bulk and surface-modified microfiltration membrane for simultaneous blood plasma harvesting and low-density lipoprotein removal during plasmapheresis

  • Authors   :Dehghan, R., Barzin, J., Carbonell, R.G., Ghaderi Jafarbeigloo, H., Kordkatooli, Z.
  • Journal    :Journal of Membrane Science
  • Year         :2024

Evaluation of solubility parameters and relative energy difference (RED) on the preparation of polysulfone/polyethylene glycol membrane: A study on the casting solution and coagulation bath

Membrane patterning through horizontally aligned microchannels developed by sulfated chopped carbon fiber for facile permeability of blood plasma components in low-density lipoprotein apheresis

High cut-off membrane: evaluation of pore collapse and the synergistic effect of low and high molecular weight polyvinylpyrrolidone

Low density lipoprotein (LDL) apheresis from blood plasma via anti-biofouling tuned membrane incorporated with graphene oxide-modified carrageenan

Ms. Faezeh Aghajannataj Ahangarkola|Drug Delivery Systems | Best Researcher Award

Published on by Top Pharmaceutical

Ms. Faezeh Aghajannataj Ahangarkola |Drug Delivery Systems|Best Researcher Award|

Ms. Faezeh Aghajannataj Ahangarkola at Babol Noshirvani University of Technology,Iran

PROFILE  

Google scholar

 

Early Academic Pursuits 🎓

Faezeh Aghajannataj began her academic journey with a strong foundation in pure chemistry, earning a Bachelor of Science degree from the University of Mazandaran (UMZ) in Babolsar, Iran, in September 2018. Her undergraduate studies focused on the synthesis of pharmaceutical heterocyclics, particularly through multi-component reactions. Under the guidance of Dr. Robabeh Baharfar, Faezeh’s final project received a stellar grade of 4.0/4.0, demonstrating her early aptitude for research and her keen interest in the intersection of chemistry and pharmaceuticals.

Building on her success at UMZ, Faezeh pursued a Master of Science degree in Biotechnology at the Babol Noshirvani University of Technology (BNUT), Babol, Iran. Her graduate research centered on the development of enteric hard capsules for targeting the small intestine, utilizing innovative materials like Pullulan and Eudragit L-100. This research culminated in a thesis titled “Enteric Hard Capsules for Targeting Small Intestine by Pullulan and Eudragit L-100: Processing, Characterization, and In-vitro Drug Release,” which was awarded a perfect grade of 4.0/4.0 (19/20), reflecting the high quality and significance of her work under the mentorship of Dr. Ghasem Najafpour.

Professional Endeavors 🏢

Faezeh’s professional career is marked by a strong focus on research and development in the pharmaceutical and biotechnology industries. During her time at Iran Gelatin Capsule in Tehran, she played a pivotal role as a member of the R&D team from February 2022 to May 2023. Her work primarily involved researching and formulating pullulan capsules at an industrial scale, a task that required both technical expertise and innovative thinking. Additionally, she contributed to the formulation and evaluation of controlled release systems designed to produce enteric-coated capsules without synthetic materials or external coatings, a project that aligns with the growing demand for more natural and sustainable pharmaceutical solutions.

Faezeh also gained significant experience as a teaching assistant during her academic career. She assisted in courses such as Organic Chemistry Laboratory and Physical Chemistry Laboratory at UMZ, and Advanced Engineering Mathematics at BNUT, showcasing her ability to convey complex scientific concepts to students. Her teaching roles not only enriched her understanding of the subjects but also allowed her to contribute to the academic growth of her peers.

Contributions and Research Focus 🔬

Faezeh’s research interests lie at the crossroads of biotechnology, pharmaceutical sciences, and chemistry. Her master’s thesis on enteric hard capsules represents a significant contribution to the field of drug delivery systems, particularly in the development of targeted delivery mechanisms for the small intestine. This work, which involved detailed processing, characterization, and in-vitro drug release studies, has the potential to impact the way oral medications are formulated and administered, particularly in terms of improving drug efficacy and patient outcomes.

Her research has been recognized through the publication of her work in reputable scientific journals. One notable publication is “Towards a Novel Pullulan and Pullulan-Enteric Hard Capsules: Study of Drug Release and Crucial Capsule Features,” co-authored with Dr. Gh. Najafpour and R. Ramezani. This paper, accessible , highlights the innovative approach Faezeh has taken in her research, contributing valuable knowledge to the field of drug delivery systems.

Accolades and Recognition 🏆

Throughout her academic and professional career, Faezeh has consistently achieved high marks and recognition for her work. Her thesis was awarded a perfect grade, reflecting the high esteem in which her research is held. Additionally, her academic achievements during her bachelor’s and master’s studies are underscored by her strong GPA, which stands at 3.6/4.0 (16.95/20) for her master’s degree, and her consistently high grades in her coursework.

Her work has also been recognized within the academic community through her roles as a teaching assistant, where she earned the trust of her professors to guide and mentor students in complex scientific subjects.

Impact and Influence 🌍

Faezeh’s research on drug delivery systems, particularly her focus on enteric capsules, has the potential to significantly impact the pharmaceutical industry. By developing more effective and targeted drug delivery mechanisms, her work could lead to improved patient outcomes, particularly for those with conditions that require precise delivery of medication to the small intestine.

Her influence extends beyond her research, as her roles as a teaching assistant and R&D member have allowed her to mentor and collaborate with others in the field, spreading her knowledge and fostering innovation in both academic and industrial settings.

Legacy and Future Contributions 🌟

Faezeh Aghajannataj is poised to make lasting contributions to the fields of biotechnology and pharmaceutical sciences. Her innovative approach to drug delivery systems and her commitment to research excellence set her apart as a leading figure in her field. As she continues her career, her work is likely to inspire future research and development in the industry, particularly in the creation of more sustainable and effective pharmaceutical solutions.

🎓Publication 

Ethanol fermentation in an immobilized cell reactor using Saccharomyces cerevisiae

  • Authors   :Ghasem Najafpour, Habibollah Younesi, Ku Syahidah Ku Ismail
  • Journal    :Bioresource technology
  • Year         :2024

Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations

  • Authors   :Leila Gorgani, Maedeh Mohammadi, Ghasem D Najafpour, Maryam Nikzad
  • Journal    :Comprehensive reviews in food science and food safety
  • Year         :2017

High-rate anaerobic digestion of palm oil mill effluent in an upflow anaerobic sludge-fixed film bioreactor

  • Authors   :GD Najafpour, AAL Zinatizadeh, AR Mohamed, M Hasnain Isa, H Nasrollahzadeh
  • Journal    :Process Biochemistry
  • Year         :2006

Treatment of pulp and paper mill wastewater by polyacrylamide (PAM) in polymer induced flocculation

  • Authors   :SS Wong, TT Teng, AL Ahmad, A Zuhairi, G Najafpour
  • Journal    :Journal of hazardous materials
  • Year         :2006

Power generation from organic substrate in batch and continuous flow microbial fuel cell operations

  • Authors   :Mostafa Rahimnejad, Ali Asghar Ghoreyshi, Ghasem Najafpour, Tahereh Jafary
  • Journal    :Applied Energy
  • Year         :2011

Prof. Cedrick MUTOMBO SHAKALENGA |Medicinal Chemistry| Best Researcher Award

Published on by Top Pharmaceutical

Prof. Cedrick MUTOMBO SHAKALENGA,Medicinal Chemistry,Best Researcher Award

Prof. Cedrick MUTOMBO SHAKALENGA, at University of Lubumbashi,Democratic Republic Congo

PROFILE

Orcid

Scopus

Google scholar

📚Early Academic Pursuits :

Cedrick Mutombo Shakalenga was born on February 26, 1991, in Manono, a town located in the Democratic Republic of Congo. His academic journey began in Mukushi / Manono Primary School, where he obtained his Primary School Certificate in 2003. Cedrick then pursued secondary education at the Bunyinge / Manono Institute, earning a State Diploma in General Pedagogy in 2009. His passion for pharmaceutical sciences led him to enroll at the University of Lubumbashi, where he completed a Pharmacist Diploma with a specialization in Hospital & Community Pharmacy in 2016.

🏢Professional Endeavors :

Cedrick’s professional career is marked by significant milestones and diverse roles within the pharmaceutical field. His early work experience includes teaching at Maendeleo/Lusa Primary School in Manono from 2009 to 2010 and serving as a Pharmacist at the Tamtam Pharmacy in Lubumbashi during 2014-2015. His academic career took off when he joined the University of Lubumbashi’s Faculty of Pharmaceutical Sciences as a Teaching Assistant from 2018 to 2022.

In 2023, Cedrick was promoted to Associate Professor at the same institution, where he now lectures on Biophysics I and II and Traditional Medicine. Additionally, he has contributed significantly to the scientific community through his role as a Scientific Research Officer at the “Jardin d’Etude Pharmaceutiques” club.

🔬Contributions and Research Focus :

Cedrick’s research is centered on integrating traditional medicine into the official health system of DR Congo. His Ph.D. thesis, titled “Conditions for the Integration of Traditional Medicine into the Official Health System in DR Congo, Case of Lubumbashi city,” reflects his dedication to this cause. He has co-authored several influential publications that explore various aspects of traditional medicine, pharmacognosy, and public health. His research not only highlights the socio-economic importance of medicinal plants but also addresses public health challenges in DR Congo.

 

🏅Accolades and Recognition :

Cedrick’s dedication and contributions to the field of pharmaceutical sciences have been widely recognized. In 2023, he received the prestigious “Peter Hylands award” for his poster presentation at the 11th Annual Meeting of The Good Practice in Traditional Chinese Medicine Research Association (GP-TCM RA). His research on the authentication of Securidaca longepedunculata Fresen., a highly sought-after medicinal plant, earned him this accolade.

🌍Impact and Influence :

Cedrick’s work has had a profound impact on the field of traditional medicine in DR Congo. His efforts to integrate traditional practices into the formal health system have the potential to improve healthcare accessibility and affordability for many Congolese citizens. By advocating for the scientific validation and quality control of traditional medicines, Cedrick is helping to bridge the gap between traditional and modern medical practices.

🚀Legacy and Future Contributions :

Cedrick Mutombo Shakalenga’s legacy lies in his unwavering commitment to enhancing the pharmaceutical landscape in DR Congo. His pioneering research and advocacy for traditional medicine integration have set a foundation for future advancements in the field. As an Associate Professor, he continues to inspire and mentor the next generation of pharmaceutical scientists, ensuring that his impact will resonate for years to come.

📝Conclusion :

Cedrick Mutombo Shakalenga’s journey from a small town in Manono to becoming an influential figure in pharmaceutical sciences is a testament to his dedication, hard work, and visionary approach. His contributions to traditional medicine, his extensive research portfolio, and his role as an educator highlight his multifaceted impact on the scientific community and society at large. Cedrick’s ongoing efforts and future endeavors promise to further advance the integration of traditional and modern medicine, ultimately improving healthcare outcomes in DR Congo and beyond.

🎓Publication 

Quality control of herbal drugs and preparations: The methods of analysis, their relevance and applications

  • Authors   :N.W Muyumba, S.C Mutombo, H Sheridan, A Nachtergael, Duez P
  • Journal    :Talanta Open
  • Year         : 2021

Perceptions and use of traditional African medicine in Lubumbashi, Haut-Katanga province (DR Congo): A cross-sectional study

    • Authors :SC Mutombo, AS Bakari, NV Ntabaza, A Nachtergael, SJB Lumbu, P Duez, BJ Kahumba
    • Journal   :PLoS ONE
    • Year       : 2022

Knowledge, attitudes and practices among the population, towards COVID-19 in the Lubumbashi city (DR Congo): An online cross-sectional survey

  • Authors  :MH Manya, SC Mutombo, CV Bashige, Nzuzi MG, TA Kabamba, MA Mutombo, MC Kibwe, MO Moke, JC Nkwanga, NT Nsumbu, AS Bakari, BJ Kahumba, SJB Lumbu
  • Journal    :World Journal of Biology Pharmacy and Health Sciences
  • Year         :  2021

Knowledge, attitude, and practice towards hepatitis B and C viruses among the population of Lubumbashi, Democratic Republic of Congo

  • Authors  :TA Kabamba, MH Manya, SC Mutombo, BC Kasongo, CKC Kakisingi, KS Matanda, MA Mutombo, MC Mwamba, NA Ngulu, MB Kabamba, OA Longanga
  • Journal   :African Journal of Gastroenterology and Hepatology
  • Year        :   2023

 

Mineral elements analysis and total flavonoids content in the fresh leaves from two varieties of Hibiscus sabdariffa L. consumed as vegetable in Lubumbashi (DR Congo)

  • Authors  :Shakalenga Cedrick Mutombo, Mboni Henry Manya, Nkulu Salvator Nsenga, Mavungu Gaël Nzuzi, Mwenya Cynthia Kibwe, Mwinensenge James Maloba, Chiribagula Valentin Bashige, Amuri Salvius Bakari, Byanga Joh Kahumba, Badibanga Bualufu Victor Ndibualonji
  • Journal   :World Journal of Advanced Research and Reviews
  • Year        :   2021

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development,Best Researcher Award-1133

Published on by Top Pharmaceutical

Prof.Mohamed Abdel-Aziz, Drug Discovery and Development ,Best Researcher Award

Prof.Mohamed Abdel-Aziz, at National Research Centre,Egypt

Author Profile

🎓 Education:

He earned his PhD in Microbiology from Ain Shams University, specializing in Physiological and Genetical Studies on Dextranase Formation by Fungi. His academic journey includes a Master’s degree from Mansoura University and a Bachelor’s degree in Botany.

🔍 Research Focus:

Dr. Abdel-Aziz’s research primarily focuses on Microbial Chemistry, with extensive contributions to understanding microbial enzymes and bioactive compounds.

🌐 International Collaborations:

He has participated in several scientific missions and collaborations worldwide, including Italy, Great Britain, China, Germany, and Sweden, enriching his research with diverse perspectives.

📘 Publications:

Dr. Abdel-Aziz has authored over 145 publications, including original articles, reviews, and books, notably contributing to advancements in microbiology and biotechnology.

🏆 Achievements:

He holds seven patents and has been involved in numerous national and international research projects, enhancing the field’s knowledge and applications.

🌟 Recognition:

With an h-index of 31 and over 3000 citations, his work continues to influence the scientific community globally.

🎓Publication Top Noted:

Paper Title : Effect of plasma superficial treatments on antibacterial functionalization and coloration of cellulosic fabrics

  • Authors: Eid B. M. and Abdel-Aziz M. S. Ibrahim N. A.
  • Journal: Applied Surface Science
  • Year: 2017
Paper Title :Preparation of polystyrene nanocomposites based on silver nanoparticles using marine bacterium for packaging
    • Authors: Ahmed M Youssef, Mohamed S Abdel-Aziz
    • Journal:Polymer-Plastics Technology and Engineering
    • Year: 2013
Paper Title : Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012
Paper Title :Seven naphtho-γ-pyrones from the marine-derived fungus Alternaria alternata: structure elucidation and biological properties
  • Authors: Mohamed Shaaban, Khaled A Shaaban, Mohamed S Abdel-Aziz
  • Journal:Organic and medicinal chemistry letters
  • Year: 2012

Paper Title :Design, synthesis and biological investigation of certain pyrazole-3-carboxylic acid derivatives as novel carriers for nitric oxide

  • Authors: El-Shimaa MN Abdel-Hafez, Gamal El-Din AA Abuo-Rahma, Mohamed Abdel-Aziz, Mohamed F Radwan, Hassan H Farag
  • Journal:Bioorganic & medicinal chemistry
  • Year: 2009